COMRAD - comparative radiation hybrid mapping
 
introduction
background
participants
maps and markers
projects
Roslin Institute

 

Markers

BTA 7

Framework markers
Marker ID
Primer 1
Primer 2
Retention Frequency
Gene Name
F6
AGLA260
GGGTTAAGCATTTTGGACAAAATTC
TTGGACTTACCATTTCTCTGTAATT
0.223
 
 
BL1043
GACTTGACCGTTCCACCTG
AGTGCCAAAAGGAAGCGC
0.117
 
F2
BL1067
ATGGTTCCGCAGAGAAACAG
AGCCAGTTTCTTCAAATCAACC
0.245
 
F1
BL5
ACCATCATTTAACCCATATCAACC
CATGGACAGAGAAGTCTGGTAGG
0.33
 
 
BM1557
AGGCTTTGGTGCATCTGTG
TGCTTGCATGATTAGATGTGG
0.287
 
 
BM2607
TTCCTGTGGGCTGGCTAG
GGCCTGTGACTCCTTGTAGG
0.309
 
 
BM6105
ACTAATAAGAAATTCTGCATGTGTG
CCACCATGACTCAGAAGTAGTTC
0.255
 
F4
BM6117
GTTCTGAGGTTTGTAAAGCCC
GGTGAGCTACAATCCATAGGG
0.181
 
 
BM7160
TGGATTTTTAAACACAGAATGTGG
TCAGCTTCTCTTTAAATTTCTCTGG
0.319
 
F6
BM7208
GCCCCAACCACTAATGATGA
TCTCTTGACTTCCTTCCTTTGC
0.138
 
F4
BM7247
AATCTTTCCCTAGAACTTACAAAGG
AGTAAGGCCTGCAGTATTTATATCC
0.213
 
 
BM741
CCAAAAGGTCCTATCTCCAAA
GCCCCTGAAGGAATGGTG
0.213
 
 
BM9065
GTCAACCTCAGCAAAACTGATG
ACTCTCCCTCCACACAGGG
0.16
 
F6
BMS1247
GGGGTTAATGGTGATCTGCA
TCAGCTCTCAGCAGCCTGTA
0.149
 
 
BMS1331
TTCTGGTGTGCAACTGTATTTG
GGTGGGCTACAGTCTATGGG
0.194
 
F6
BMS1979
GTTTTCTGGAAATCTGTTTAATGC
TTCTTTTTATATCTCCCCCTTCA
0.213
 
F6
BMS2209
TGTGCCGCGTAGAGAGATTA
TGTGCCGCGTAGAGAGATTA
0.17
 
F5
BMS2258
AGTGGTAGAACTTCCATCTCACA
CCAGCAGAAGAGAAAGATACTGA
0.178
 
 
BMS522
CCCAACAAAATTTCTGATTCTC
CTTGCTTACTGCTTGCTATGAA
0.16
 
 
BMS713
ACCAGCAGTAGGTTGAGGTTAA
CCAAGGGAGGAAAAATAAGTTAA
0.301
 
F5
BMS792
GCAAGCCCTAGGCTGAAA
AGCATGTATCCAATCTACCCTG
0.223
 
F5
BMS904
TGTGATATCCACTTTCCCCG
GTCCTTTGTTCGTTCTAGCAGG
0.223
 
F3
BOBT24
GAGCAAGGGAATTCAGTGGAGC
TGTATTTTACATTCAGGTCTGTGATCC
0.223
 
 
BP41
AAGAACCCGCTTCCAAGG
TCCCATCTTCACCAAAGAGC
0.213
 
 
CSKB071
TACTGTCCTTTCTCCCCACTCC
CTATGTCAATAGCCCCCACC
0.255
 
 
CSSM020
CCATGTTAGAGACAAAGACTGCCA
AGATGCACTGAGCTGGCAAACCAC
0.213
 
F4
CSSM029
GCTCCATTATGCACATGCCATGCT
CGTGAGAACCGAAAGCACACATTC
0.287
 
F5
CSSM057
GAGGGGATAGGGAAGAGAGAA
GCATTTCTTTTTCCAGTGTGGT
0.161
 
 
DIK050
CAGACATCCACAAGGAAAC
AACCAAGATGGGGAAGTACA
0.287
 
F2
DIK079
CATGGGATCGCGAAGAGTAG
CAACCCCAAGGAAATTTTCATTC
0.266
 
F2
IDVGA62
GGGATCTTGGACCAGAAGGTA
GGTGACACTCCTCCCATCT
0.277
 
F2
IDVGA90
GCCCGTACACCACATAGCA
TGACAGTCCCCAGGCACTAA
0.287
 
 
IL4*
ACATTCAGGTCTGTGATCCATG
GTGCTGGACATCTGCAAGTG
0.213
interleukin 4
F1
ILSTS001
GGAGTCATACACAACTGAGC
GGTGCTGTTATCTAGAATTTGG
0.202
 
F6
ILSTS006
ACACGGAAGCGATCTAAACG
TGTCTGTATTTCTGCTGTGG
0.16
 
 
INRA053
ATTCCATGGACAGAGGAGCCT
CACCAGAAATTCACTTCACCT
0.17
 
 
INRA112
GATCTAACTAGAGCTTTCC
GCCTCTCAAAGCCACCTGC
0.277
 
F5
INRA192
TGTTTTAATTTGCATTTCCTGA
GACCTTTACAGCCACCTCTTC
0.191
 
 
INRA229
TCTAAGGCCAGGAAGACAAAC
CTTGGGAGTAATGAGTCGAGTA
0.096
 
 
OarAE129
GTAGATCAAGATATAGAATATTTTTCAACACC
AATCCAGTGTGTGAAAGACTAATCCAG
0.213
 
F6
RASA1
GGGCCACAGCCCAGGATCGGGAGC
CCCTTCCGCTTTAGTGCAGCCAG
0.149
 
 
RIc11A
GGGATCATCTCAAAAGTTCCACG
GTAAGATATGTATAATGCTGGCC
0.209
 
F3
RM006
GATCACCATATTTATGAGATGG
CTACAATATCTGGTCACTGGA
0.309
 
F1
RM012
ACTGGGAACCAAGGACTGTCA
CTGAGCTCAGGGGTTTTTGCT
0.202
 
 
RME30
CCATGGGAGAAAAGGGAAAT
TTGATGTACTGCATCGGAGG
0.223
 
 
TGLA164
CATGACTGAAGCAACTTAGCATG
CTTGATGGAACTAAAACTAAAACTG
0.181
 
F1
TGLA176
TCAAGGCACAAGCACACAGTCA
AGTAGGAATACCCCAGGAGGAA
0.34
 
F3
TGLA303
TAATCATAAGTCAAAGTAACAGTTT
GATCTGGACATACAAAAGTATTAC
0.298
 
 
TGLA48
ACATGACTCTGCCATAGAGCAT
AAATGTTTTATCTTGACTACTAAGC
0.213
 
F3
URB051
TCCACCCGGTGGTCACCTAAA
ACAGCAGTGAACGGAGTGGAA
0.319
 
F4
UWCA20
CTGAAACACTCTAAAAGGGTATGC
ATCCCAACATCCACCCATTCC
0.181
 

back to main choice

© Roslin Institute 2002

Dr John Williams
0131 527 4200